Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of intraventricular CT-010 for drug-resistant focal temporal lobe epilepsy
MOH_2020-10-19_009418Phase 2Recruiting
- Sponsor
- Cerebral Therapeutics
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Focal Onset Epilepsy and temporal lobe epilepsy (TLE) comparing CT-010 with Placebo comparator (2 arms). Started Oct 2020; status: recruiting.
02
Drugs
valproic acid
03
Conditions
Focal Onset Epilepsytemporal lobe epilepsy (TLE)
Beyond the preview
Go deeper on MOH_2020-10-19_009418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-10-19_009418.